Zhen-Ge Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Zhen-Ge Luo has a total of 227 co-authors. Here are the top co-authors by number of shared publications:
Peng-Ming Zeng
School of Life Science and Technology & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, Shanghai 201210, China
9 shared publicationsXiu-Qing Fu
School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China
8 shared publicationsXin-Yao Sun
School of Life Science and Technology & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, Shanghai 201210, China; Institute of Neuroscience, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai 200031, China
7 shared publicationsYang Li
School of Life Science and Technology, ShanghaiTech University , Shanghai 201210
7 shared publicationsJian Peng
School of Life Science and Technology & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University
6 shared publicationsXiang-Chun Ju
Okinawa Institute of Science and Technology Graduate University, Okinawa 904-0495, Japan
6 shared publications
Latest Publications
- 23 April 2026
- Published by Elsevier in Molecular Therapy
- Vol. 34 (8) , 4482-4501
SEC62-mediated ER-phagy activation alleviates Alzheimer’s disease pathology and restores cognitive function in 5×FAD mice
- 23 April 2026
- Published by Elsevier in Molecular Therapy
- Vol. 34 (8) , 4482-4501
SEC62-mediated ER-phagy activation alleviates Alzheimer’s disease pathology and restores cognitive function in 5×FAD mice
- Open Access
- 28 March 2026
- Published by Oxford University Press (OUP) in National Science Review
- Vol. 13 (8)
DISC1 mutant macaques capture behavioral and neural hallmarks of psychiatric disease
Schizophrenia is a devastating and complex neurological disorder with poorly understood neurodevelopmental origins. Current rodent models often fail to fully capture human symptomology, hindering therapeutic development. We generated a germline-transmissible DISC1 mutant model in cynomolgus macaques using CRISPR-Cas9 targeting of exon 9. F0 founders and their F1 heterozygous offspring displayed increased stereotypic behaviors and self-injury, reduced exploration, social withdrawal, and sleep fragmentation. Fluoxetine partially ameliorated these behaviors in one founder. Neuroimaging revealed enlarged dorsal striatum (suggesting dopaminergic hyperfunction) and reduced medial amygdala (associated with emotional dysregulation). Plasma metabolomics indicated elevated dopamine and 3-methoxytyramine alongside decreased serotonin metabolite hydroxyindoleacetic acid (HIAA). Notably, one mosaic male exhibited enhanced visual precision and aberrant multisensory integration. Single-nuclei RNA sequencing of the dorsolateral prefrontal cortex revealed an excitatory/inhibitory imbalance—specifically, reduced parvalbumin-positive interneurons and synaptic dysregulation—accompanied by downregulation of autism-risk genes. These macaques recapitulate key psychiatric phenotypes including social deficits, aggression and anxiety, providing a valuable model for screening and testing of targeted therapeutics.
- 28 March 2026
- Published by Oxford University Press (OUP) in National Science Review
- Vol. 13 (8)
Open AccessDISC1 mutant macaques capture behavioral and neural hallmarks of psychiatric disease
Schizophrenia is a devastating and complex neurological disorder with poorly understood neurodevelopmental origins. Current rodent models often fail to fully capture human symptomology, hindering therapeutic development. We generated a germline-transmissible DISC1 mutant model in cynomolgus macaques using CRISPR-Cas9 targeting of exon 9. F0 founders and their F1 heterozygous offspring displayed increased stereotypic behaviors and self-injury, reduced exploration, social withdrawal, and sleep fragmentation. Fluoxetine partially ameliorated these behaviors in one founder. Neuroimaging revealed enlarged dorsal striatum (suggesting dopaminergic hyperfunction) and reduced medial amygdala (associated with emotional dysregulation). Plasma metabolomics indicated elevated dopamine and 3-methoxytyramine alongside decreased serotonin metabolite hydroxyindoleacetic acid (HIAA). Notably, one mosaic male exhibited enhanced visual precision and aberrant multisensory integration. Single-nuclei RNA sequencing of the dorsolateral prefrontal cortex revealed an excitatory/inhibitory imbalance—specifically, reduced parvalbumin-positive interneurons and synaptic dysregulation—accompanied by downregulation of autism-risk genes. These macaques recapitulate key psychiatric phenotypes including social deficits, aggression and anxiety, providing a valuable model for screening and testing of targeted therapeutics.
- Open Access
Hopx expression marks Aβ clearance astrocytes in Alzheimer’s disease
SUMMERY: Astrocytic dysfunction is closely associated with nearly all types of neurological diseases. Targeting astrocyte regulation has thus emerged as an important potential therapeutic strategy for neurological disorders. However, mechanisms that induce astrocyte dysfunction under pathological conditions have not been fully elucidated. In this study, we identified that Homeodomain-only protein X ( Hopx ) is downregulated in astrocytes across inflammatory models, Alzheimer’s disease (AD) mouse models, and brain tissues from AD patients. In the brains of AD mice, Hopx-positive astrocytes exhibit efficient β-amyloid (Aβ) plaque clearance, while knockout of Hopx leads to astrocytic dysfunction. Conversely, astrocyte-specific overexpression of Hopx not only significantly enhances their Aβ phagocytic function but also effectively reduces the generation of neurotoxic astrocytes while increasing protective astrocytes. In summary, this study demonstrates the core regulatory mechanism underlying astrocytic dysfunction under AD pathological conditions and provides important potential targets for developing therapeutic strategies for AD by targeting astrocyte regulatory pathways.
Open AccessHopx expression marks Aβ clearance astrocytes in Alzheimer’s disease
SUMMERY: Astrocytic dysfunction is closely associated with nearly all types of neurological diseases. Targeting astrocyte regulation has thus emerged as an important potential therapeutic strategy for neurological disorders. However, mechanisms that induce astrocyte dysfunction under pathological conditions have not been fully elucidated. In this study, we identified that Homeodomain-only protein X ( Hopx ) is downregulated in astrocytes across inflammatory models, Alzheimer’s disease (AD) mouse models, and brain tissues from AD patients. In the brains of AD mice, Hopx-positive astrocytes exhibit efficient β-amyloid (Aβ) plaque clearance, while knockout of Hopx leads to astrocytic dysfunction. Conversely, astrocyte-specific overexpression of Hopx not only significantly enhances their Aβ phagocytic function but also effectively reduces the generation of neurotoxic astrocytes while increasing protective astrocytes. In summary, this study demonstrates the core regulatory mechanism underlying astrocytic dysfunction under AD pathological conditions and provides important potential targets for developing therapeutic strategies for AD by targeting astrocyte regulatory pathways.
- 6 February 2026
- Published by Elsevier in Journal of Genetics and Genomics
- Vol. 53 (7) , 1159-1179
Gene-targeted versus broad-spectrum therapies in ALS: comparative lessons and strategic outlook
- 6 February 2026
- Published by Elsevier in Journal of Genetics and Genomics
- Vol. 53 (7) , 1159-1179
Gene-targeted versus broad-spectrum therapies in ALS: comparative lessons and strategic outlook
- Open Access
Joint Segmental Duplication Co-option Drives Human-specific Transcriptional Readthrough and Expression Fine-tuning of NPEPPS - TBC1D3
Segmental duplication (SD) is a major driver of functional changes in evolution and disease. Many genes embedded within SDs, such as NPEPPS and TBC1D3 , display substantial copy number variation (CNV) across individuals. Yet, the precise identification of the functional copies and their transcriptional outputs remains largely unstudied. Focusing on NPEPPS and TBC1D3 , we illustrate human-specific expression fine-tuning mechanisms associated with readthrough transcripts. We identified a human-specific NPEPPS - TBC1D3 digenic genomic structure that originated from a joint SD pair and became fixed across populations. Experiments demonstrate that this structure generates NPEPPS - TBC1D3 readthrough transcripts, which are the predominant isoforms of TBC1D3 expression in various cell types, fine-tuning its protein level. Furthermore, a human-specific hypomethylation signal within an upstream CpG island of NPEPPS precisely pinpoints the expressed TBC1D3 paralog. Moreover, we reveal transcriptional readthrough events are ∼3-fold enriched for joint-SD-associated transcriptional readthrough (JSDTR) and identify 109 JSDTR gene pairs, including neurodevelopmentally important pairs and clinically interesting SERF1A/B-SMN1/2 . Taken together, our findings comprehensively describe an example of how a joint SD event shaped evolution and suggest that JSDTR is a broad mechanism for the emergence of new functions.
Open AccessJoint Segmental Duplication Co-option Drives Human-specific Transcriptional Readthrough and Expression Fine-tuning of NPEPPS - TBC1D3
Segmental duplication (SD) is a major driver of functional changes in evolution and disease. Many genes embedded within SDs, such as NPEPPS and TBC1D3 , display substantial copy number variation (CNV) across individuals. Yet, the precise identification of the functional copies and their transcriptional outputs remains largely unstudied. Focusing on NPEPPS and TBC1D3 , we illustrate human-specific expression fine-tuning mechanisms associated with readthrough transcripts. We identified a human-specific NPEPPS - TBC1D3 digenic genomic structure that originated from a joint SD pair and became fixed across populations. Experiments demonstrate that this structure generates NPEPPS - TBC1D3 readthrough transcripts, which are the predominant isoforms of TBC1D3 expression in various cell types, fine-tuning its protein level. Furthermore, a human-specific hypomethylation signal within an upstream CpG island of NPEPPS precisely pinpoints the expressed TBC1D3 paralog. Moreover, we reveal transcriptional readthrough events are ∼3-fold enriched for joint-SD-associated transcriptional readthrough (JSDTR) and identify 109 JSDTR gene pairs, including neurodevelopmentally important pairs and clinically interesting SERF1A/B-SMN1/2 . Taken together, our findings comprehensively describe an example of how a joint SD event shaped evolution and suggest that JSDTR is a broad mechanism for the emergence of new functions.
- Open Access
- 15 August 2025
- Published by Elsevier in Stem Cell Reports
- Vol. 20 (9) , 102601
Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids
- 15 August 2025
- Published by Elsevier in Stem Cell Reports
- Vol. 20 (9) , 102601
Open AccessThymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids
- Open Access
- 22 April 2025
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 41 (10) , 1779-1791
Neural Responses to Hypoxic Injury in a Vascularized Cerebral Organoid Model
Hypoxic injury (HI) in the prenatal period often causes neonatal neurological disabilities. Due to the difficulty in obtaining clinical samples, the molecular and cellular mechanisms remain unclear. Here we use vascularized cerebral organoids to investigate the hypoxic injury phenotype and explore the intercellular interactions between vascular and neural tissues under hypoxic conditions. Our results indicate that fused vascularized cerebral organoids exhibit broader hypoxic responses and larger decreases in panels of neural development-related genes when exposed to low oxygen levels compared to single cerebral organoids. Interestingly, vessels also exhibit neural protective effects on T-box brain protein 2+ intermediate progenitors (IPs), which are markedly lost in HI cerebral organoids. Furthermore, we identify the role of bone morphogenic protein signaling in protecting IPs. Thus, this study has established an in vitro organoid system that can be used to study the contribution of vessels to brain injury under hypoxic conditions and provides a strategy for the identification of intervention targets.
- 22 April 2025
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 41 (10) , 1779-1791
Open AccessNeural Responses to Hypoxic Injury in a Vascularized Cerebral Organoid Model
Hypoxic injury (HI) in the prenatal period often causes neonatal neurological disabilities. Due to the difficulty in obtaining clinical samples, the molecular and cellular mechanisms remain unclear. Here we use vascularized cerebral organoids to investigate the hypoxic injury phenotype and explore the intercellular interactions between vascular and neural tissues under hypoxic conditions. Our results indicate that fused vascularized cerebral organoids exhibit broader hypoxic responses and larger decreases in panels of neural development-related genes when exposed to low oxygen levels compared to single cerebral organoids. Interestingly, vessels also exhibit neural protective effects on T-box brain protein 2+ intermediate progenitors (IPs), which are markedly lost in HI cerebral organoids. Furthermore, we identify the role of bone morphogenic protein signaling in protecting IPs. Thus, this study has established an in vitro organoid system that can be used to study the contribution of vessels to brain injury under hypoxic conditions and provides a strategy for the identification of intervention targets.
- Open Access
- 24 July 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (8) , 114548
A hominoid-specific signaling axis regulating the tempo of synaptic maturation
- 24 July 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (8) , 114548
Open AccessA hominoid-specific signaling axis regulating the tempo of synaptic maturation
- Open Access
- 13 July 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (7) , 114514
Comparative transcriptomic profiling reveals a role for Olig1 in promoting axon regeneration
- 13 July 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (7) , 114514
Open AccessComparative transcriptomic profiling reveals a role for Olig1 in promoting axon regeneration
- Open Access
- 23 February 2024
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
High-throughput mapping of single-neuron projection and molecular features by retrograde barcoded labeling
Deciphering patterns of connectivity between neurons in the brain is a critical step toward understanding brain function. Imaging-based neuroanatomical tracing identifies area-to-area or sparse neuron-to-neuron connectivity patterns, but with limited throughput. Barcode-based connectomics maps large numbers of single-neuron projections, but remains a challenge for jointly analyzing single-cell transcriptomics. Here, we established a rAAV2-retro barcode-based multiplexed tracing method that simultaneously characterizes the projectome and transcriptome at the single neuron level. We uncovered dedicated and collateral projection patterns of ventromedial prefrontal cortex (vmPFC) neurons to five downstream targets and found that projection-defined vmPFC neurons are molecularly heterogeneous. We identified transcriptional signatures of projection-specific vmPFC neurons, and verified Pou3f1 as a marker gene enriched in neurons projecting to the lateral hypothalamus, denoting a distinct subset with collateral projections to both dorsomedial striatum and lateral hypothalamus. In summary, we have developed a new multiplexed technique whose paired connectome and gene expression data can help reveal organizational principles that form neural circuits and process information.
- 23 February 2024
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Open AccessHigh-throughput mapping of single-neuron projection and molecular features by retrograde barcoded labeling
Deciphering patterns of connectivity between neurons in the brain is a critical step toward understanding brain function. Imaging-based neuroanatomical tracing identifies area-to-area or sparse neuron-to-neuron connectivity patterns, but with limited throughput. Barcode-based connectomics maps large numbers of single-neuron projections, but remains a challenge for jointly analyzing single-cell transcriptomics. Here, we established a rAAV2-retro barcode-based multiplexed tracing method that simultaneously characterizes the projectome and transcriptome at the single neuron level. We uncovered dedicated and collateral projection patterns of ventromedial prefrontal cortex (vmPFC) neurons to five downstream targets and found that projection-defined vmPFC neurons are molecularly heterogeneous. We identified transcriptional signatures of projection-specific vmPFC neurons, and verified Pou3f1 as a marker gene enriched in neurons projecting to the lateral hypothalamus, denoting a distinct subset with collateral projections to both dorsomedial striatum and lateral hypothalamus. In summary, we have developed a new multiplexed technique whose paired connectome and gene expression data can help reveal organizational principles that form neural circuits and process information.